Company / Gross Profit per Share
Repligen Gross Profit per Share History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.69
FY2019
5-year range
-
FY2018-FY2019
Trend
+24.1%
vs FY2018
Sector context
#26 of 29
Health Care
What the data says
Among 29 Health Care companies, Repligen is in the bottom 10% for gross profit per share.
Based on SEC 10-K filings.
0.69 in FY2019.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 29This company $0.69 Sector average $8.11
▼
-91.5% below sector average
Key checks
Key Insights
- In FY2019, gross profit per share increased 24.1% year-over-year.
- Ranks #26 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0.69 | +24.1% |
| FY2018 | $0.55 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026